XEOMIN 200 unités, poudre pour solution injectable, Placebo of Xeomin 200 U
P170912J
Phase 3 small_molecule active
Quick answer
XEOMIN 200 unités, poudre pour solution injectable, Placebo of Xeomin 200 U for Adult patients with indication for conventional cardiac surgery (CABG, aortic replacement, or ascending aorta surgery) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients with indication for conventional cardiac surgery (CABG, aortic replacement, or ascending aorta surgery)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active